Publications
Showing 271-285 from 1626 publications.
- Roquer J, Rodríguez-Campello A, Cuadrado-Godia E, Giralt-Steinhauer E, Jiménez-Conde J, Soriano C, Ois A. The role of HbA1c determination in detecting unknown glucose disturbances in ischemic stroke.
PLoS ONE 2014; 9(12): e109960
IF: 3.534, Quartile: 1
- Ill-Raga G, Palomer E, Ramos-Fernández E, Guix FX, Bosch-Morató M, Guivernau B, Tajes M, Valls-Comamala V, Jiménez-Conde J, Ois A, Pérez-Asensio F, Reyes-Navarro M, Caballo C, Gil-Gómez G, Lopez-Vilchez I, Galán AM, Alameda F, Escolar G, Opazo C, Planas A, Planas AM, Roquer J, Valverde MA, Muñoz FJ. Fibrinogen nitrotyrosination after ischemic stroke impairs thrombolysis and promotes neuronal death.
Biochim. Biophys. Acta 2015 Mar; 1852(3): 421-8
IF: 5.089, Quartile: 1
- Rodríguez-Campello A, Jiménez-Conde J, Ois A, Cuadrado-Godia E, Giralt-Steinhauer E, Schroeder H, Romeral G, Llop M, Soriano-Tarraga C, Garralda-Anaya M, Roquer J. Dietary habits in patients with ischemic stroke: a case-control study.
PLoS ONE 2014; 9(12): e114716
IF: 3.534, Quartile: 1
- Sanchis J, Bonanad C, Ruiz V, Fernández J, García-Blas S, Mainar L, Ventura S, Rodríguez-Borja E, Chorro FJ, Hermenegildo C, Bertomeu-González V, Núñez E, Núñez J. Frailty and other geriatric conditions for risk stratification of older patients with acute coronary syndrome.
Am. Heart J. 2014 Nov; 168(5): 784-91
IF: 4.555, Quartile: 1
- Zamora A, Carrion C, Vazquez-Oliva G, Paluzie G, Martín-Urda A, Elosua R. Theoretical impact on coronary disease of using a computerized clinical decision support system in the prescription of lipid-lowering treatment.
Rev Esp Cardiol (Engl Ed) 2015 Jan; 68(1): 75-8
IF: 3.342, Quartile: 2
- Urra X, San Román L, Gil F, Millán M, Cánovas D, Roquer J, Cardona P, Ribó M, Martí-Fàbregas J, Abilleira S, Chamorro A. Medical and endovascular treatment of patients with large vessel occlusion presenting with mild symptoms: an observational multicenter study.
Cerebrovasc. Dis. 2014; 38(6): 418-24
IF: 3.698, Quartile: 1
- Majersik JJ, Cole JW, Golledge J, Rost NS, Chan YF, Gurol ME, Lindgren AG, Woo D, Fernandez-Cadenas I, Chen DT, Thijs V, Worrall BB, Kamal A, Bentley P, Wardlaw JM, Ruigrok YM, Battey TW, Schmidt R, Montaner J, Giese AK, Roquer J, Jiménez-Conde J, Lee C, Ay H, Martin JJ, Rosand J, Maguire J. Recommendations from the international stroke genetics consortium, part 1: standardized phenotypic data collection.
Stroke 2015 Jan; 46(1): 279-84
IF: 6.018, Quartile: 1, Decile: 1
- Battey TW, Valant V, Kassis SB, Kourkoulis C, Lee C, Anderson CD, Falcone GJ, Jiménez-Conde J, Fernandez-Cadenas I, Pare G, Rundek T, James ML, Lemmens R, Lee TH, Tatlisumak T, Kittner SJ, Lindgren A, Mateen FJ, Berkowitz AL, Holliday EG, Majersik J, Maguire J, Sudlow C, Rosand J. Recommendations from the international stroke genetics consortium, part 2: biological sample collection and storage.
Stroke 2015 Jan; 46(1): 285-90
IF: 6.018, Quartile: 1, Decile: 1
- Heras M, Bayés-Genís A, Perez de Isla L, Sanchis J, Avanzas P. Continuing medical education: a priority in Revista Española de Cardiología.
Rev Esp Cardiol (Engl Ed) 2014 Dec; 67(12): 1068-73
IF: 3.342, Quartile: 2
- Abilleira S, Ribera A, Dávalos A, Ribó M, Chamorro A, Cardona P, Molina CA, Martínez-Yélamos A, Urra X, Dorado L, Roquer J, Martí-Fàbregas J, Aja L, Tomasello A, Castaño C, Blasco J, Cánovas D, Castellanos M, Krupinski J, Guimaraens L, Perendreu J, Ustrell X, Purroy F, Gómez-Choco M, Baiges JJ, Cocho D, Saura J, Gallofré M. Functional outcome after primary endovascular therapy or IV thrombolysis alone for stroke. An observational, comparative effectiveness study.
Cerebrovasc. Dis. 2014; 38(5): 328-36
IF: 3.698, Quartile: 1
- Ay H, Arsava EM, Andsberg G, Benner T, Brown RD, Chapman SN, Cole JW, Delavaran H, Dichgans M, Engström G, Giralt-Steinhauer E, Grewal RP, Gwinn K, Jern C, Jiménez-Conde J, Jood K, Katsnelson M, Kissela B, Kittner SJ, Kleindorfer DO, Labovitz DL, Lanfranconi S, Lee JM, Lehm M, Lemmens R, Levi C, Li L, Lindgren A, Markus HS, McArdle PF, Melander O, Norrving B, Peddareddygari LR, Pedersén A, Pera J, Rannikmäe K, Rexrode KM, Rhodes D, Rich SS, Roquer J, Rosand J, Rothwell PM, Rundek T, Sacco RL, Schmidt R, Schürks M, Seiler S, Sharma P, Slowik A, Sudlow C, Thijs V, Woodfield R, Worrall BB, Meschia JF. Pathogenic ischemic stroke phenotypes in the NINDS-stroke genetics network.
Stroke 2014 Dec; 45(12): 3589-96
IF: 6.018, Quartile: 1, Decile: 1
- Valgimigli M, Campo G, de Cesare N, Meliga E, Vranckx P, Furgieri A, Angiolillo DJ, Sabaté M, Hamon M, Repetto A, Colangelo S, Brugaletta S, Parrinello G, Percoco G, Ferrari R. Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: results from the double-blind, prospective, randomized Tailoring Treatment with Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel study.
Circulation 2009 Jun; 119(25): 3215-22
IF: 14.816, Quartile: 1, Decile: 1
- Kastrati A, Mehilli J, Pache J, Kaiser C, Valgimigli M, Kelbaek H, Menichelli M, Sabaté M, Suttorp MJ, Baumgart D, Seyfarth M, Pfisterer ME, Schömig A. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents.
N. Engl. J. Med. 2007 Mar; 356(10): 1030-9
IF: 52.589, Quartile: 1, Decile: 1
- Stettler C, Wandel S, Allemann S, Kastrati A, Morice MC, Schömig A, Pfisterer ME, Stone GW, Leon MB, de Lezo JS, Goy JJ, Park SJ, Sabaté M, Suttorp MJ, Kelbaek H, Spaulding C, Menichelli M, Vermeersch P, Dirksen MT, Cervinka P, Petronio AS, Nordmann AJ, Diem P, Meier B, Zwahlen M, Reichenbach S, Trelle S, Windecker S, Jüni P. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis.
Lancet 2007 Sep; 370(9591): 937-48
IF: 28.638, Quartile: 1, Decile: 1
- Stitziel NO, Won HH, Morrison AC, Peloso GM, Do R, Lange LA, Fontanillas P, Gupta N, Duga S, Goel A, Farrall M, Saleheen D, Ferrario P, König I, Asselta R, Merlini PA, Marziliano N, Notarangelo MF, Schick U, Auer P, Assimes TL, Reilly M, Wilensky R, Rader DJ, Hovingh GK, Meitinger T, Kessler T, Kastrati A, Laugwitz KL, Siscovick D, Rotter JI, Hazen SL, Tracy R, Cresci S, Spertus J, Jackson R, Schwartz SM, Natarajan P, Crosby J, Muzny D, Ballantyne C, Rich SS, O'Donnell CJ, Abecasis G, Sunyaev S, Nickerson DA, Buring JE, Ridker PM, Chasman DI, Austin E, Ye Z, Kullo IJ, Weeke PE, Shaffer CM, Bastarache LA, Denny JC, Roden DM, Palmer C, Deloukas P, Lin DY, Tang ZZ, Erdmann J, Schunkert H, Danesh J, Marrugat J, Elosua R, Ardissino D, McPherson R, Watkins H, Reiner AP, Wilson JG, Altshuler D, Gibbs RA, Lander ES, Boerwinkle E, Gabriel S, Kathiresan S. Inactivating mutations in NPC1L1 and protection from coronary heart disease.
N. Engl. J. Med. 2014 Nov; 371(22): 2072-82
IF: 54.42, Quartile: 1, Decile: 1
An initiative of
